Antibiotice S.A. (BVB:ATB)

Market Cap	1.20B -17.5%
Revenue (ttm)	660.04M -4.2%
Net Income	51.77M -49.3%
EPS	0.08 -49.3%
Shares Out	671.34M
PE Ratio	23.11
Forward PE	n/a
Dividend	0.04 (1.97%)
Ex-Dividend Date	Oct 1, 2026

Volume	219,624
Average Volume	304,485
Open	1.828
Previous Close	1.826
Day's Range	1.812 - 1.848
52-Week Range	1.750 - 2.725
Beta	0.28
RSI	34.12
Earnings Date	May 27, 2026

About Antibiotice

Antibiotice S.A. produces and sells medicinal products in Romania and internationally. The company offers generic prescription medicines comprising anti-infectives, including drugs for the treatment of tuberculosis, as well as cardiovascular drugs, digestive tract and metabolism class, preparations for the treatment of gynecological diseases, and dermatological and central nervous system preparations; generic non-prescription medicines, including food supplements, cosmetics, and medical devices; active substances; biofertilizers; biocides for d...

• Industry: Pharmaceutical Preparations
• Founded: 1955
• Employees: 1,356
• Stock Exchange: Bucharest Stock Exchange
• Ticker Symbol: ATB

Financial Performance

In 2025, Antibiotice's revenue was 660.04 million, a decrease of -4.16% compared to the previous year's 688.70 million. Earnings were 51.77 million, a decrease of -49.35%.